The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval
Melanoma is recognized as the most dangerous type of skin cancer, with high mortality and resistance to currently used treatments. To overcome the limitations of the available therapeutic options, the discovery and development of new, more effective, and safer therapies is required. In this review,...
Guardado en:
Autores principales: | Mariana Matias, Jacinta O. Pinho, Maria João Penetra, Gonçalo Campos, Catarina Pinto Reis, Maria Manuela Gaspar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c9bd8ca4173949738bc5f7d540a5d5c3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New Insight to Overcome Tumor Resistance: An Overview from Cellular to Clinical Therapies
por: Giulia Mitola, et al.
Publicado: (2021) -
Inherited and Acquired Rhythm Disturbances in Sick Sinus Syndrome, Brugada Syndrome, and Atrial Fibrillation: Lessons from Preclinical Modeling
por: Laura Iop, et al.
Publicado: (2021) -
Comparisons of in vitro Fick’s first law, lipolysis, and in vivo rat models for oral absorption on BCS II drugs in SNEDDS
por: Ye J, et al.
Publicado: (2019) -
In Vitro and In Vivo Models to Assess the Immune-Related Effects of Nanomaterials
por: Diana Boraschi, et al.
Publicado: (2021) -
<i>Dyrk1a</i> from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome
por: Helin Atas-Ozcan, et al.
Publicado: (2021)